DrugPatentWatch Database Preview

VRAYLAR Drug Profile

« Back to Dashboard

When do Vraylar patents expire, and what generic alternatives are available?

Vraylar is a drug marketed by Allergan Sales Llc and is included in one NDA. There are two patents protecting this drug.

This drug has eighty-two patent family members in thirty-seven countries.

The generic ingredient in VRAYLAR is cariprazine hydrochloride. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cariprazine hydrochloride profile page.

Summary for VRAYLAR

International Patents:	82
US Patents:	2
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	22
Clinical Trials:	2
Patent Applications:	18
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for VRAYLAR
Prior Art and Litigation Support	Order Prior Art and Litigation support for VRAYLAR
DailyMed Link:	VRAYLAR at DailyMed

Generic Entry Opportunity Date for VRAYLAR

NDA:

204370

Dosage:

CAPSULE;ORAL

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Pharmacology for VRAYLAR

Drug Class

Atypical Antipsychotic

Synonyms for VRAYLAR

1083076-69-0

3-((1R,4r)-4-(2-(4-(2,3-dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)-1,1-dimethylurea hydrochloride

AKOS027338713

BCP24194

Cariprazine (hydrochloride)

Cariprazine HCl

CARIPRAZINE HYDROCHLORIDE

Cariprazine hydrochloride (JAN/USAN)

Cariprazine hydrochloride [USAN]

cariprazine monohydrochloride

cariprazine.HCl

CHEBI:90932

CHEMBL2024517

CS-1570

D09876

EX-A1644

FT-0701196

HY-14763A

KQD7C255YG

KS-00000640

MolPort-044-723-876

N'-(Trans-4-(2-(4-(2,3-dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)-N,N-dimthylurea monohydrochloride

N'-(trans-4-{2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl}cyclohexyl)-N,N-dimethylurea hydrochloride

RGH-188 HCL

RGH-188 hydrochloride

SB16840

SCHEMBL183803

SCHEMBL183804

UNII-KQD7C255YG

Urea, N'-(trans-4-(2-(4-(2,3-dichlorophenyl)-1-piperazinyl)ethyl)cyclohexyl)-N,N- dimethyl-, hydrochloride (1:1)

Vraylar (TN)

US Patents and Regulatory Information for VRAYLAR

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Allergan Sales Llc	VRAYLAR	cariprazine hydrochloride	CAPSULE;ORAL	204370-001	Sep 17, 2015		RX	Yes	No			Y	Y
Allergan Sales Llc	VRAYLAR	cariprazine hydrochloride	CAPSULE;ORAL	204370-002	Sep 17, 2015		RX	Yes	No
Allergan Sales Llc	VRAYLAR	cariprazine hydrochloride	CAPSULE;ORAL	204370-001	Sep 17, 2015		RX	Yes	No
Allergan Sales Llc	VRAYLAR	cariprazine hydrochloride	CAPSULE;ORAL	204370-003	Sep 17, 2015		RX	Yes	No
Allergan Sales Llc	VRAYLAR	cariprazine hydrochloride	CAPSULE;ORAL	204370-002	Sep 17, 2015		RX	Yes	No

International Patents for VRAYLAR

Country	Patent Number	Estimated Expiration
Taiwan	200505874
South Korea	20150090264
Luxembourg	C00039
Japan	3999806
Canada	2684404

Supplementary Protection Certificates for VRAYLAR

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1663996	2017C/045	Belgium		PRODUCT NAME: CARIPRAZINE, EVENTUELLEMENT SOUS LA FORME D'UN SEL, Y COMPRIS L'HYDROCHLORURE DE CARIPRAZINE; AUTHORISATION NUMBER AND DATE: EU/1/17/1209 20170717
1663996	CR 2017 00042	Denmark		PRODUCT NAME: CARIPRAZINE, OPTIONALLY IN THE FORM OF A SALT, INCLUDING THE CARIPRAZINE HYDROCHLORIDE; REG. NO/DATE: EU/1/17/1209 20170717
1663996	300913	Netherlands		PRODUCT NAME: CARIPRAZINE, OPTIONEEL IN DE VORM VAN EEN ZOUT, WAARONDER CARIPRAZINE HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/17/1209 20170717
1663996	17C0008	France		PRODUCT NAME: CARIPRAZINE,FACULTATIVEMENT SOUS FORME D'UN SEL,INCLUANT L'HYDROCHLORURE DE CARIPRAZINE.; REGISTRATION NO/DATE: EU/1/17/1209 20170717
1663996	2017/050	Ireland		PRODUCT NAME: CARIPRAZINE, OPTIONALLY IN THE FORM OF A SALT, INCLUDING THE CARIPRAZINE HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/17/1209 20170713